104 results
DEFA14A
PCSA
Processa Pharmaceuticals Inc
29 Apr 24
Additional proxy soliciting materials
4:31pm
Statement
Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials …
Soliciting Materials Pursuant to §240.14a-12
Processa Pharmaceuticals, Inc.
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy
8-K
EX-10.1
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
materials, including the exhibits thereto and documents incorporated by reference therein, together with the Pricing Prospectus and the Prospectus, being … , releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials
8-K
3dgvgily
16 Oct 23
Regulation FD Disclosure
9:15am
DEFA14A
wvwt e9zb8qhcm
5 Oct 23
Additional proxy soliciting materials
10:01am
DEFA14A
o4km0c aoloh1m2
1 May 23
Additional proxy soliciting materials
10:01am
8-K
wq1srp6
22 Dec 22
Regulation FD Disclosure
2:53pm
8-K
mdnax4pxcgrhao
6 Sep 22
Regulation FD Disclosure
9:46pm
8-K
sk5jss
14 Jul 22
Departure of Directors or Certain Officers
3:51pm
DEFA14A
rj1s bjbib
31 May 22
Additional proxy soliciting materials
8:05am